Prevention and management of respiratory viruses

Document Type


Publication Date



Respiratory viruses are increasingly recognized as a cause of community-acquired pneumonia in both children and adults. Oseltamivir is recommended for the treatment of influenza virus in the inpatient setting, while ribavirin should be considered for the treatment of respiratory syncytial virus in selected infants and children. Pharmacists are in a key position to actively work with healthcare personnel and providers to choose the most appropriate antiviral regimen for a patient infected with a respiratory virus; to ensure that appropriate infection control measures are followed; and to provide recommendations for effective steps to prevent the spread of infection.

This document is currently not available here.